Prasol Chemicals Limited IPO Details

Factual IPO information from public filings. Not investment advice.

Issue Details

Price Band: ₹643 – ₹676
Lot Size: 22 shares
Min. Investment: ₹14,872
Total Issue Size: ₹500 Cr; 73,96,437 shares
Fresh Issue: ₹80 Cr; 11,83,431 shares
Offer for Sale: ₹420 Cr; 62,13,006 shares
Face Value: ₹2 per share
Issue Type: Book-built IPO
Listing At: BSE, NSE
Shares Pre-Issue: 5,80,00,000
Shares Post-Issue: 5,91,83,431

Lot Size & Investment

1 lot = 22 shares

Retail (min)

1 lot · 22 shares

Retail (max)

13 lots · 286 shares

S-HNI (min)

14 lots · 308 shares

Application	Lots	Shares	Amount
Retail	1	22	₹14,872
Small HNI (S-HNI)	14	308	₹2,08,208
Big HNI (B-HNI)	68	1,496	₹10,11,296

Financial Performance

Restated figures in ₹ crore, unless stated otherwise

Financial performance by period
Period	Mar-26	Mar-25	Mar-24
Assets	839.28	723.09	626.36
Total Income	1,237.85	1,015.54	887.56
Profit After Tax	83.12	43.57	18.13
EBITDA	139.32	87.77	60.53
Net Worth	448.51	367.46	325.84
Reserves & Surplus	436.91	355.87	314.24
Total Borrowing	110.06	101.05	82.07

Key Performance Indicators

Key performance indicators
Period	Mar-26
RoNW (%)	18.53
EPS (₹)	14.33

About Prasol Chemicals Limited

Incorporated in 1992, Prasol Chemicals operates in the specialty chemicals industry. The company manufactures over 150 specialty chemicals, including acetone-based, phosphorous-based, and other complex chemicals. Its product portfolio includes 21 acetone-based chemicals, 53 phosphorous-based chemicals, and 76 other specialty chemicals (e.g. surfactants, esters, acids). The products serve 5 major industries, including Performance chemicals (like lubricant and mining additives), paint, inks, construction, and adhesives (PICA), pharmaceuticals, agrochemicals, and home and personal care. Manufacturing Facility: The company operates two manufacturing facility in Khopoli across 1,20,604 sq. m., Mahad across 1,19,423 sq. mt with an aggregate capacity of 98,644 MT per year. Key customers: Alembic Pharmaceuticals, Lubrizol India, Rossari Biotech, Clean Science, Gharda Chemicals, Croda India, Supriya Lifescience, Yasho Industries, etc. As of July 31, 2026, the company served 1600 customers and exports to 69 countries. It is certified as a 3 Star Export House by the Indian government and have a strong global distribution network across APAC, North and South America, and Europe. Competitive Strengths: Highly diversified product portfolio used across various Application Industries Well established R&D capabilities driving innovation with strong pipeline of products Long standing relationships with a diversified customer base and strong global presence Experienced, Qualified and Professional Leadership Team Robust financial performance track record